Matthew R. Strickland
Massachusetts General Hospital(US)Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, vaccines and immunoinformatics approaches, Viral-associated cancers and disorders, Gastric Cancer Management and Outcomes, Gastrointestinal Tumor Research and Treatment
Most-Cited Works
- → Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells(2017)2,117 cited
- → Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma(2020)294 cited
- → Cancer Vulnerabilities Unveiled by Genomic Loss(2012)237 cited
- → Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models and Clinical Data from Patients with KRASG12C-Mutant Non–Small Cell Lung Cancer(2022)119 cited
- → PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling(2014)116 cited
- → Management of Locally Advanced Rectal Cancer: ASCO Guideline(2024)115 cited
- → Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis(2021)90 cited
- → Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker(2023)76 cited
- → Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas(2016)69 cited
- → Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition(2022)50 cited